Filter publications
Customer Publications (A total of 3421 papers published)
Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis
American Journal of Cancer Research (e-Century Publishing) Taiwan , 03 September 2023
Oncology
Key words: Deubiquitinating enzyme, chondrosarcoma, apoptosis, endoplasmic reticulum stress [more]
Organism: Mouse
Tissue: Xenograft Tumor
Pathological State: Cancer
Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota
Aging (Impact Journals) Taiwan , 02 September 2023
Neuroscience, Gastroenterology
Key words: Alzheimer’s disease, plasmon-activated water, fecal microbiota transplantation, microbiota, beta amyloid, tau [more]
Organism: Mouse
Tissue: Brain
Pathological State: Alzheimer’s disease
Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma
Precision Clinical Medicine (Oxford Academic) China, The Netherlands , 02 September 2023
Oncology
Organism: Human
Tissue: Liver
Pathological State: Cancer
Mesenchymal stem cells promote polarization of M2 macrophages in mice with acute-on-chronic liver failure via Mertk/JAK1/STAT6 signaling
Stem Cells (Oxford Academic) China , 02 September 2023
Stem Cell Research, Hepathology
Key words: mesenchymal stem cell, acute-on-chronic liver failure, macrophage, polarization, Mertk, JAK1/STAT6 [more]
Organism: Mouse
Tissue: Liver
Pathological State: Liver failure
Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4
Frontiers in Immunology (Frontiers Media S.A.) China, South Korea , 01 September 2023
Immunology
Key words: fimH, macrophage polarization, toll-like receptor 4, myeloid differentiation factor 2, tumor-associated macrophage [more]
Organism: Mouse
Tissue: Allograft Tumor
Pathological State: Cancer
Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma
Nature Immunology (Nature) USA , 31 August 2023
Oncology, Immunology
Key words: Cancer immunotherapy, Immunosurveillance, Stem cells, Tumour immunology [more]
Cell Line: HMC3 microglia, 293T cells, CT2A cells, SIM-A9 microglia, and SB28 and GL261 cells
The Cooperative Human Tissue Network of the National Cancer Institute: Supporting cancer research for 35 years
Molecular Cancer Therapeutics (AACR) USA , 30 August 2023
Oncology
Engineering tumoral vascular leakiness with gold nanoparticles
Nature Communications (Nature) Singapore, China, Japan, Australia , 30 August 2023
Oncology, Nanomedicine
Key words: Cancer, Nanoscale materials [more]
Organism: Mouse
Tissue: Xenograft Tumor, Heart, Liver, Spleen, Lung, Kidney
Pathological State: Cancer
FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth
Cell Reports (Cell Press) China , 29 August 2023
Oncology
Key words: CDK4, CP: Cancer, CP: Molecular biology, CRC, FRMD8, MDM2, RB. [more]
Organism: Human
Tissue: Colon
Pathological State: Cancer
Synergy of 5-aminolevulinate supplement and CX3CR1 suppression promotes liver regeneration via elevated IGF-1 signaling
Cell Reports (Cell Press) China , 29 August 2023
Hepathology
Key words: 5-aminolevulinate, CP: Immunology, CP: Metabolism, CX3CR1, P53, hepatectomy, hepatocyte proliferation, insulin-like growth factor 1, liver regeneration, liver zonation, macrophage polarization, partial liver transplantation [more]
Organism: Mouse
Tissue: Liver












